Strongyloidiasis

• FDA approval · 2026-04-07
  FDA Approved: IVERMECTIN — Original Application (Ajanta Pharma USA Inc.)

  FDA approved Ajanta Pharma USA Inc.'s original ANDA for ivermectin, making a generic version of the product available for human use. The app…

• FDA approval · 2024-09-04
  FDA Approved: ALBENDAZOLE — Original Application (Alembic Pharmaceuticals Inc.)

  FDA approves Alembic Pharmaceuticals' original application for albendazole, adding a generic version to the market.

• FDA approval · 2024-08-19
  FDA Approved: IVERMECTIN — Supplemental Application (Edenbridge Pharmaceuticals LLC.)

  FDA approved a supplemental application for IVERMECTIN from Edenbridge Pharmaceuticals LLC (ANDA 204154). This action updates the approval s…

• FDA approval · 2022-08-02
  FDA Approved: IVERMECTIN — Original Application (Viona Pharmaceuticals Inc)

  FDA approves an original ANDA for ivermectin tablets from Viona Pharmaceuticals Inc, enabling a generic version of the antiparasitic for cer…

• FDA approval · 2020-07-09
  FDA Approved: IVERMECTIN — Supplemental Application (Actavis Pharma, Inc.)

  The FDA approved a supplemental application for Actavis Pharma’s ivermectin, confirming approval of its generic antiparasitic product.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2009-10-20
  FDA Approved: ALBENDAZOLE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

  FDA approved a supplemental application for Albendazole submitted by Amneal Pharmaceuticals of New York LLC.

• FDA approval · 2008-02-26
  FDA Approved: STROMECTOL — Supplemental Application (Merck Sharp & Dohme LLC)

  FDA approved a supplemental application for Stromectol (ivermectin) filed by Merck Sharp & Dohme LLC, granting changes to the drug's labelin…